Use of CRISPR-based antivirals as broad-spectrum therapeutics.
Abstract not provided.
- Research Organization:
- Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- DOE Contract Number:
- NA0003525
- OSTI ID:
- 2005670
- Report Number(s):
- SAND2022-14587C; 711135
- Country of Publication:
- United States
- Language:
- English
Similar Records
Designing Broad-Spectrum Antivirals.
CRISPR pooled library screens offer an effective tool for identifying therapeutic targets against broad viral families.
Broad-Spectrum Analysis of Personnel Movements Pre- and Post-COVID.
Conference
·
Fri Jan 31 23:00:00 EST 2014
·
OSTI ID:1315036
CRISPR pooled library screens offer an effective tool for identifying therapeutic targets against broad viral families.
Conference
·
Sat Oct 01 00:00:00 EDT 2022
·
OSTI ID:2005946
Broad-Spectrum Analysis of Personnel Movements Pre- and Post-COVID.
Conference
·
Fri Jul 01 00:00:00 EDT 2022
·
OSTI ID:2004229